Literature DB >> 12044876

Biochemical properties of the human REV1 protein.

Yuji Masuda1, Kenji Kamiya.   

Abstract

It has been proposed that the REV1 protein plays an important role in the induced-mutagenesis pathway. We show that purified REV1 protein inserts dCMP opposite template G, A, T and C, and dGMP and dTMP opposite template G in the presence of magnesium, while in the presence of manganese the specificity for dCMP was found to be relaxed and the REV1 protein acquired the ability to insert dCMP, dGMP, dAMP and dTMP opposite templates G, A, T, and C. Kinetic analysis provided evidence for high affinity for dCTP with template G, suggesting that the REV1 protein is specialized for dCTP and template G.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12044876     DOI: 10.1016/s0014-5793(02)02773-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  REV1 accumulates in DNA damage-induced nuclear foci in human cells and is implicated in mutagenesis by benzo[a]pyrenediolepoxide.

Authors:  Suparna Mukhopadhyay; Denise R Clark; Nicholas B Watson; Wolfgang Zacharias; W Glenn McGregor
Journal:  Nucleic Acids Res       Date:  2004-11-02       Impact factor: 16.971

2.  Kinetic basis of nucleotide selection employed by a protein template-dependent DNA polymerase.

Authors:  Jessica A Brown; Jason D Fowler; Zucai Suo
Journal:  Biochemistry       Date:  2010-07-06       Impact factor: 3.162

3.  AtREV1, a Y-family DNA polymerase in Arabidopsis, has deoxynucleotidyl transferase activity in vitro.

Authors:  Shinya Takahashi; Ayako N Sakamoto; Atsushi Tanaka; Kikuo Shimizu
Journal:  Plant Physiol       Date:  2007-09-07       Impact factor: 8.340

4.  Translesional DNA synthesis through a C8-guanyl adduct of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in Vitro: REV1 inserts dC opposite the lesion, and DNA polymerase kappa potentially catalyzes extension reaction from the 3'-dC terminus.

Authors:  Hirokazu Fukuda; Takeji Takamura-Enya; Yuji Masuda; Takehiko Nohmi; Chiho Seki; Kenji Kamiya; Takashi Sugimura; Chikahide Masutani; Fumio Hanaoka; Hitoshi Nakagama
Journal:  J Biol Chem       Date:  2009-07-23       Impact factor: 5.157

Review 5.  Variations on a theme: eukaryotic Y-family DNA polymerases.

Authors:  M Todd Washington; Karissa D Carlson; Bret D Freudenthal; John M Pryor
Journal:  Biochim Biophys Acta       Date:  2009-07-17

6.  Quantitative analysis of the efficiency and mutagenic spectra of abasic lesion bypass catalyzed by human Y-family DNA polymerases.

Authors:  Shanen M Sherrer; Kevin A Fiala; Jason D Fowler; Sean A Newmister; John M Pryor; Zucai Suo
Journal:  Nucleic Acids Res       Date:  2010-09-15       Impact factor: 16.971

7.  The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis.

Authors:  Jacob G Jansen; Anastasia Tsaalbi-Shtylik; Petra Langerak; Fabienne Calléja; Caro M Meijers; Heinz Jacobs; Niels de Wind
Journal:  Nucleic Acids Res       Date:  2005-01-13       Impact factor: 16.971

8.  Overexpression of Rev1 promotes the development of carcinogen-induced intestinal adenomas via accumulation of point mutation and suppression of apoptosis proportionally to the Rev1 expression level.

Authors:  Megumi Sasatani; Yang Xi; Junko Kajimura; Toshiyuki Kawamura; Jinlian Piao; Yuji Masuda; Hiroaki Honda; Kei Kubo; Takahiro Mikamoto; Hiromitsu Watanabe; Yanbin Xu; Hidehiko Kawai; Tsutomu Shimura; Asao Noda; Kanya Hamasaki; Yoichiro Kusunoki; Elena Karamfilova Zaharieva; Kenji Kamiya
Journal:  Carcinogenesis       Date:  2017-05-01       Impact factor: 4.944

9.  Vertebrate DNA damage tolerance requires the C-terminus but not BRCT or transferase domains of REV1.

Authors:  Anna-Laura Ross; Laura J Simpson; Julian E Sale
Journal:  Nucleic Acids Res       Date:  2005-03-01       Impact factor: 16.971

10.  Rev1 is a base excision repair enzyme with 5'-deoxyribose phosphate lyase activity.

Authors:  Rajendra Prasad; Vladimir Poltoratsky; Esther W Hou; Samuel H Wilson
Journal:  Nucleic Acids Res       Date:  2016-09-28       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.